Literature DB >> 1732412

Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein.

A R Neurath1, N Strick, P Sproul.   

Abstract

The major target organ for hepatitis B virus (HBV) is the liver. However, cells other than hepatocytes, including peripheral blood lymphocytes and monocytes, may become infected with HBV. The cell receptor binding site was assigned to the preS(21-47) segment of the HBV envelope protein. HBV receptors were detected on human liver and hepatoma cells, on B lymphocytes, and, as shown here, on monocytes, and T cell lines, activated by Escherichia coli lipopolysaccharide and concanavalin A, respectively. The cell receptors for HBV have not been characterized until now. The detection of HBV receptors and their "activation antigen" characteristic on distinct cells suggested paths for identification of the receptors with already defined cell surface proteins. This search revealed that interleukin 6 contains recognition sites for the preS(21-47) sequence and mediates HBV-cell interactions. Thus, HBV belongs to a group of viruses utilizing cytokines or cytokine receptors for replication and interference with the host immune system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732412      PMCID: PMC2119103          DOI: 10.1084/jem.175.2.461

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

Review 1.  Proteoglycans as modulators of growth factor activities.

Authors:  E Ruoslahti; Y Yamaguchi
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

2.  Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands.

Authors:  M A Petit; N Strick; S Dubanchet; F Capel; A R Neurath
Journal:  Mol Immunol       Date:  1991 Apr-May       Impact factor: 4.407

3.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

Review 4.  Proteoglycans: structures and interactions.

Authors:  L Kjellén; U Lindahl
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

5.  The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction.

Authors:  S T Wong; L F Winchell; B K McCune; H S Earp; J Teixidó; J Massagué; B Herman; D C Lee
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

6.  Infection by mink cell focus-forming viruses confers interleukin 2 (IL-2) independence to an IL-2-dependent rat T-cell lymphoma line.

Authors:  P N Tsichlis; S E Bear
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  Epidermal growth factor receptor occupancy inhibits vaccinia virus infection.

Authors:  D A Eppstein; Y V Marsh; A B Schreiber; S R Newman; G J Todaro; J J Nestor
Journal:  Nature       Date:  1985 Dec 19-1986 Jan 1       Impact factor: 49.962

8.  Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

Authors:  D H Hsu; R de Waal Malefyt; D F Fiorentino; M N Dang; P Vieira; J de Vries; H Spits; T R Mosmann; K W Moore
Journal:  Science       Date:  1990-11-09       Impact factor: 47.728

9.  HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47).

Authors:  M A Petit; S Dubanchet; F Capel; P Voet; C Dauguet; P Hauser
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

10.  T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor.

Authors:  C A Smith; T Davis; J M Wignall; W S Din; T Farrah; C Upton; G McFadden; R G Goodwin
Journal:  Biochem Biophys Res Commun       Date:  1991-04-15       Impact factor: 3.575

View more
  27 in total

1.  Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.

Authors:  Ji Chen; Yan Wang; Xue-Jie Wu; Jun Li; Feng-Qin Hou; Gui-Qiang Wang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 2.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  How the key finds its door - identification of HBV receptor.

Authors:  Yun Wang; Xinwen Chen
Journal:  Virol Sin       Date:  2013-01-16       Impact factor: 4.327

Review 4.  Molecular biology of the hepatitis B virus for clinicians.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Vijay Veer; Runu Chakravarty
Journal:  J Clin Exp Hepatol       Date:  2012-10-18

5.  Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition.

Authors:  Azeneth Barrera; Bernadette Guerra; Lena Notvall; Robert E Lanford
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.

Authors:  Qiang Deng; Jian-wei Zhai; Marie-Louise Michel; Jun Zhang; Jun Qin; Yu-ying Kong; Xin-xin Zhang; Agata Budkowska; Pierre Tiollais; Yuan Wang; You-hua Xie
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

Review 7.  Deciphering the mystery of hepatitis B virus receptors: A historical perspective.

Authors:  Zaira Rehman; Ammad Fahim; Hajra Sadia
Journal:  Virusdisease       Date:  2015-07-03

Review 8.  Liver disease.

Authors:  S D Ryder; R Williams
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

9.  Pre-structured motifs in the natively unstructured preS1 surface antigen of hepatitis B virus.

Authors:  Seung-Wook Chi; Do-Hyoung Kim; Si-Hyung Lee; Iksoo Chang; Kyou-Hoon Han
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

10.  Compartmentalization of hepatitis B virus: Looking beyond the liver.

Authors:  Sibnarayan Datta
Journal:  World J Hepatol       Date:  2015-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.